Skip to content
OpenCapital
Get started

Integra LifeSciences IART Current ratio

Current ratio at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
0.9×-0.2×
Stryker logo
StrykerSYK
2.1×+0.5×
Axogen logo
AxogenAXGN
7.1×+2.8×
Globus Medical logo
Globus MedicalGMED
4.6×+0.1×
AbbVie logo
AbbVieABBV
0.8×0.0×
Medtronic logo
MedtronicMDT
2.1×+0.3×

Other financials

Income statement

See full
Revenue$391.9M+2.4%
Gross profit$217.0M+11.6%
Operating income$11.5M+174%
Net income-$4.6M+81.7%
EPS (diluted)-$0.06+81.8%

Balance sheet

See full
Cash & equivalents$236.8M-1.0%
Total debt$2.0B+3.2%
Total equity$1.0B-31.6%
Total assets$3.6B-11.7%

Cash flow

See full
Operating cash flow$9.8M+187%
CapEx$14.8M-48.7%
Free cash flow-$5.0M+87.4%

Valuation

See full
Market cap$1.38B-56.8%
Enterprise value$3.12B-26.7%
P/S0.8×-1.1×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin-29.8%-30.3pp
Net margin-30.1%—
FCF margin3.8%-6.3pp

Returns & leverage

See full
Return on equity-38.6%—
Debt / equity1.9×+0.6×

Where this comes from

Calculated from Integra LifeSciences’s reported figures.

total current assets/total current liabilities=3.4×

Based on the most recent quarter.

The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integra LifeSciences's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Integra LifeSciences's current ratio?
Integra LifeSciences (IART) reported current ratio of 3.4× in Q1 2026.
How has Integra LifeSciences's current ratio changed year-over-year?
Integra LifeSciences's current ratio increased by 180.3% year-over-year, from 1.2× to 3.4×.
What is the long-term trend for Integra LifeSciences's current ratio?
Over 5 years (2020 to 2025), Integra LifeSciences's current ratio has grown at a -3.8% compound annual growth rate (CAGR), from 3.1× to 2.5×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.